Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.

Completed

• Conditions: Multiple Myeloma

• Registration Number: NCT05163405
• Lead Sponsor: Karin B. Ø. Dieperink

Brief Summary

In the present study, we have trained 10 patients in subcutaneous self-administration of Velcade. After their training, patients will alternately receive their treatment in the hospital and at home by self-administration. In keeping with common practice, a nurse contacts the patients by telephone before 9.00 am on the day of treatment to ensure that the patient is physically "fit" to receive the medication and to discuss any side effects. To highlight the advantages and disadvantages of the changed treatment practice from the perspectives of both patients and healthcare professionals, data is collected from two consecutive semi-structured interviews with n = 10 patients and n = 1 focus group interview of the healthcare professionals involved. Moreover, time registration of medication administration both at the hospital and in the patients' home is done. The qualitative data will be analyzed via the method of condensation and continual quantitative data will form the basis of a cost-benefit analysis.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-12-01
• Study First Submitted: 2021-12-03
• Study First Submitted QC: 2021-12-17
• Study First Posted: 2021-12-20
• Primary Completion: 2022-01-01
• Study Completion: 2022-06-01
• Status Verified: 2022-11
• Last Update Submitted: 2022-11-09
• Last Update Posted: 2022-11-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients experience of self-administration of Velcade	Through study completion, from 01. dec. 2019 until 01. jun. 2022	Qualitative interviews with all 10 included patients

Secondary Outcome Measures

Name	Time	Method
Health care perspective	Through study completion, from 01. dec. 2019 until 01. jun. 2022	Focus group interview with healthcare professionals involved in the treatment.
Financial perspective	Through study completion, from 01. dec. 2019 until 01. jun. 2022	Evaluation of financial savings on home treatment including healthcare salaries and transportation.
Organizational perspective	Through study completion, from 01. dec. 2019 until 01. jun. 2022	Patients and health professionals (including pharmacy staff) registration of time spend on treatment on all 10 included patients.

Trial Locations

Locations (1)

Odense University Hospital; 🇩🇰 Odense, Denmark